Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A child presenting with bullous emphysema.
Özsezen B, Tural DA, Üner M, Özcan HN, Nurullayev E, Emiralioğlu N, Soyer T, Orhan D, Yalçın E, Doğru D, Özçelik U, Kiper N. Özsezen B, et al. Turk J Pediatr. 2022;64(5):964-969. doi: 10.24953/turkjped.2021.5515. Turk J Pediatr. 2022. PMID: 36305451 Free article.
Comparison of clinical features of cystic fibrosis patients eligible but not on CFTR modulators to ineligible for CFTR modulators.
Nayır Büyükşahin H, Emiralioğlu N, Yalçın E, Şen V, Selimoğlu Şen H, Arslan H, Başkan AK, Çakır FB, Koray CF, Yılmaz Aİ, Ercan F, Altıntaş DU, Serbes M, Keskin Ö, Arık E, Gülen F, Barlık M, Karcıoğlu O, Damadoğlu E, Köse M, Ersoy A, Bingöl A, Başaran E, Çakır EP, Aslan AT, Canıtez Y, Korkmaz M, Özdemir A, Harmancı K, Soydaş ŞS, Hangül M, Yüksel H, Özcan G, Korkmaz P, Kılıç M, Gayretli Aydın ZG, Çaltepe G, Can D, Doğru S, Kartal Öztürk G, Süleyman A, Topal E, Özsezen B, Hızal M, Demirdöğen E, Ogun H, Börekçi Ş, Yazan H, Çakır E, Şişmanlar Eyüboğlu T, Çobanoğlu N, Cinel G, Pekcan S, Özçelik U, Doğru D. Nayır Büyükşahin H, et al. Pediatr Pulmonol. 2024 Oct;59(10):2499-2506. doi: 10.1002/ppul.27051. Epub 2024 May 21. Pediatr Pulmonol. 2024. PMID: 38771207
Patients with cystic fibrosis who could not receive the CFTR modulator treatment: What did they lose in 1 year?
Uytun S, Cinel G, Eryılmaz Polat S, Özkan Tabakçı S, Kiper N, Yalçın E, Ademhan Tural D, Özsezen B, Şen V, Selimoğlu Şen H, Ufuk Altıntaş D, Çokuğraş H, Kılınç AA, Başkan AK, Yazan H, Çollak A, Uzuner S, Ünal G, Yılmaz Aİ, Çağlar HT, Damadoğlu E, Irmak İ, Demir E, Kartal Öztürk G, Bingöl A, Başaran E, Sapan N, Canıtez Y, Tana Aslan A, Asfuroğlu P, Harmancı K, Köse M, Hangül M, Özdemir A, Çobanoğlu N, Özcan G, Keskin Ö, Yüksel H, Özdoğan Ş, Topal E, Çaltepe G, Can D, Korkmaz Ekren P, Kılıç M, Emiralioğlu N, Şişmanlar Eyüboğlu T, Pekcan S, Çakır E, Özçelik U, Doğru D. Uytun S, et al. Pediatr Pulmonol. 2023 Sep;58(9):2505-2512. doi: 10.1002/ppul.26535. Epub 2023 Jun 6. Pediatr Pulmonol. 2023. PMID: 37278544
Impact of interruption of CFTR modulator therapies.
Capraz Yavuz B, Yalcin E, Nayir Buyuksahin H, Sunman B, Guzelkas I, Alboga D, Akgul Erdal M, Demir HI, Atan R, Emiralioglu N, Dogru D, Ozcelik U, Kiper N. Capraz Yavuz B, et al. J Cyst Fibros. 2024 Sep;23(5):947-949. doi: 10.1016/j.jcf.2024.05.006. Epub 2024 May 18. J Cyst Fibros. 2024. PMID: 38762388